Cat. No. Name Size Price Add Cart
KI0575H-891 mg$126.72

Chemical Characteristic

Product NameH-89
CAS No.127243-85-0
Molecular Weight 446.36
FormulaC20H20BrN3O2S
Chemical NameN-[2-[[3-(4-Bromophenyl)-2-propen-1-yl]amino]ethyl]-5-isoquinolinesulfonamide
Smilesc1nccc2c(cccc12)S(=O)(=O)NCCNC/C=C/c1ccc(cc1)Br
Chemical Structure

Biological activities

H-89 is a specific cyclic AMP-dependent protein kinase A (protein kinase A) inhibitor. H-89 inhibits protein kinase A (PKA), PKB, PKG and PKC kinases with IC50 of 0.04, 2.5, 0.88 and 15 μM, respectively.[1] H-89 has a potent and selective inhibitory action against PKA, with a Ki of 48 nM. H-89 inhibits these kinases, including PKG, PKC, casein kinase I and II, myosin light chain kinase, and Ca2+/calmodulin-dependent protein kinase II with Ki of 0.48, 31.7, 38.3, 136.7, 28.3, and 29.7 μM, respectively. H-89 also significantly inhibits the forskolin-induced neurite outgrowth from PCl2D cells. Pretreatment of PCl2D cells with H-89 (30 μM) inhibits significantly cAMP-dependent histone IIb phosphorylation activity in cell lysates. [2] Pretreatment with H-89 significantly attenuates isoproterenol-stimulated cAMP accumulation. H-89 acts as a beta-2 AR antagonist of surprisingly high affinity with a Ki of 0.18 μM. H-89 inhibits [3H]dihydroalprenolol to both beta-2 AR and beta-1 AR with Ki of 0.24 and 0.50 μM, respectively. [3] H-89 decreases Kv1.3 currents and accelerates the decay rate of current inactivation in a concentration- dependent manner with an IC50 of 1.70 μM. [4]

Protocols

H-89 is dissolved in DMSO. [4]

References

[1] Reuveni H, et al. Toward a PKB inhibitor: modification of a selective PKA inhibitor by rational design. Biochemistry. 2002, 41(32): 10304-10314.
[2] Chijiwa T, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H- 89), of PC12D pheochromocytoma cells. J Biol Chem. 1990, 265(9): 5267-5272.
[3] Penn RB, et al. Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. J Pharmacol Exp Ther. 1999, 288(2): 428-437.
[4] Choi J, et al. Inhibition of Kv1.3 channels by H-89 (N-[2- (p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) independent of protein kinase A. Biochem Pharmacol. 2001, 61(8): 1029-1032.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.